The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Items 801–900 of 1,000
Zhong, W., Shi, X., Yuan, H., Bu, H., Wu, L., & Wang, R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00735 · Cited by 10
“Studies have reported that postmenopausal women are more susceptible to having obesity, cardiometabolic diseases, osteoporosis, and sarcopenia (Carr, 2003; Fu et al., 2009; Rector et al., 2011).”
BackgroundAssociation between waist-hip ratio and coronary artery calcification in postmenopausal women
Eun, Y., Lee, S. N., Jung, J., Kim, M., Moon, K., & Yoo, K. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001581 · Cited by 9
Mitochondria: Aging, Metabolic Syndrome and Cardiovascular Diseases. Formation of a New Paradigm
Panov, A. V., Dikalov, S., Darenskaya, M. A., Рычкова, Л. В., Kolesnikova, L. I., & Kolesnikov, S. I. (2020) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2020-5.4.5 · Cited by 12
Froehle, A. W., Hopkins, S. R., Natarajan, L., & Schoeninger, M. J. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0063 · Cited by 10
“The substantial and irreversible decrease in 17β-estradiol levels during menopause, therefore, is thought to at least partly underlie the postmenopausal reduction in REE and its associated cardiovascular and metabolic health risks (Carr 2003).”
BackgroundInfluentialGalacto-oligosaccharides and bowel function
Niittynen, L., Kajander, K., & Korpela, R. (2007) · Food & Nutrition Research · doi:10.3402/fnr.v51i2.1612 · Cited by 9
Estrogen receptor α activation modulates the gut microbiome and type 2 diabetes risk factors
Shiffler, J., Goerger, K., & Gorres, B. K. (2022) · Physiological Reports · doi:10.14814/phy2.15344 · Cited by 10
“Previous studies report increased weight gain, glucose intolerance, and decreased insulin sensitivity in postmenopausal women (Carr, 2003; Pfeilschifter et al., 2002; Sites et al., 2002).”
BackgroundSun, Q., Liu, C., Li, S., Ren, J., & Wang, Z. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304098 · Cited by 8
Teppa-Garrán, A., Pérez-Peña, E., Sobrevía, L., & Marín, R. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167987 · Cited by 10
Ledesma, S. N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207315 · Cited by 11
“While this model has clinical utility, it fails to account for the striking epidemiological, metabolic, and hormonal patterns increasingly observed in FS patients, particularly in women during the menopausal transition [46,58].”
InfluentialAbdul, Y., Li, W., Vargas, J. D., Grant, E., He, L., Jamil, S., & Ergul, A. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0630 · Cited by 8
“The cardiovascular protection seen in women before menopause is lost after menopause (Arnetz et al. 2014; Carr 2003; Janghorbani et al. 1993).”
BackgroundThe role of androgens in transgender medicine
Dimakopoulou, A., Millar, O., Moschonas, D., & Jayasena, C. N. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101617 · Cited by 9
Social determinants of health and metabolic syndrome in Colombian older adults
Reyes-Ortiz, C. A., Marín-Vargas, E., & Ocampo-Chaparro, J. M. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.01.022 · Cited by 8
Steiner, B. M., Benvie, A. M., Lee, D., Jiang, Y., & Berry, D. C. (2024) · Nature Communications · doi:10.1038/s41467-024-50985-8 · Cited by 8
“After OVX, more careful characterization of adipogenesis is needed.”
MENOPAUSE AND CARDIOVASCULAR RISK
Аничков, Д. А., Shostak, N. A., & Журавлева, А. Д. (2005) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2005-1-1-37-42 · Cited by 12
Gyeong, M. Y. I. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000485 · Cited by 8
“The sex-based difference of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency after menopause [17].”
BackgroundGlycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling
Tang, Y., Lv, X., Bao, Y., & Wang, J. R. (2020) · Climacteric · doi:10.1080/13697137.2020.1828853 · Cited by 8
Hereditary Angioedema with and Without C1-Inhibitor Deficiency in Postmenopausal Women
Billebeau, A., Fain, O., Launay, D., Boccon‐Gibod, I., Bouillet, L., Gobert, D., Plu‐Bureau, G., & Gompel, A. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00902-7 · Cited by 8
Chansela, P., Potip, B., Weerachayaphorn, J., Kangwanrangsan, N., Chukijrungroat, N., & Saengsirisuwan, V. (2022) · Histochemistry and Cell Biology · doi:10.1007/s00418-021-02062-0 · Cited by 8
“In addition to diet-induced obesity, loss of ovarian function due to menopause accelerates the prevalence of metabolic diseases (Carr 2003).”
BackgroundSmith‐Ryan, A. E., Hirsch, K. R., & Cabre, H. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-21881-1_15 · Cited by 8
The brain insulin receptor gene network and associations with frailty index
Selenius, J. S., Silveira, P. P., Haapanen, M. J., von Bonsdorff, M. B., Lahti, J. M. T., Eriksson, J. G., & Wasenius, N. (2024) · Age and Ageing · doi:10.1093/ageing/afae091 · Cited by 8
“This might be due to post-menopausal women suffering more frequently from conditions related to adverse glucose and insulin metabolism than men [50] as a result of the loss of the protective effect of oestrogen [51, 52] and because of sex differences in body composition [53].”
BackgroundKim, H., & Kim, H. (2013) · Journal of Korean Biological Nursing Science · doi:10.7586/jkbns.2013.15.3.133 · Cited by 8
“연구의 필요성 폐경 이후 여성은 복부에 지방이 증가되어, 혈당이 상승하며, 혈 압 상승으로 이어지고, 고밀도콜레스테롤은 감소하고 중성지방, 총 콜레스테롤, 저밀도 콜레스테롤은 증가한다(Carr, 2003).”
Myette‐Côté, É., Doucet, É., Prud’homme, D., RABASA-LHORET, R. P. R., Lavoie, J.-M., & Brochu, M. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000273 · Cited by 10
“Thus, it is of great interest to identify factors that are associated with the variability observed in insulin sensitivity among individuals after lifestyle interventions, particularly in obese postmenopausal women who are considered at higher risk for insulin resistance and cardiometabolic abnormalities.(29) Conseque…”
BackgroundSíndrome metabólica e estado nutricional de idosos cadastrados no HiperDia
Rosa, C. B., Agostini, J. A., Bianchi, P. D., Garcês, S. B. B., Hansen, D., Moreira, P. R., & Schwanke, C. H. A. (2016) · Scientia Medica · doi:10.15448/1980-6108.2016.3.23100 · Cited by 19
“Nas mulheres, alguns fatores de risco, como resistência à insulina, obesidade central e dislipidemia (aumento nos níveis de triglicerídeos e diminuição de HDL-c), geralmente surgem com a deficiência de estrogênio durante a menopausa, o que poderia justificar o aumento da frequência de SM nesse grupo, com o envelhecime…”
BackgroundDoğan, E. S. K., Kırzıoğlu, F. Y., Doğan, B., Fentoğlu, Ö., Kale, B., Çarsancaklı, S. A., & Orhan, H. (2018) · Journal of Periodontology · doi:10.1002/jper.17-0314 · Cited by 8
Role of Sex Hormones in Human Body
Aubead, N. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95778 · Cited by 12
Daniele, A., Guarini, A., Summa, S. D., Dellino, M., Lerario, G., Ciavarella, S., Ditonno, P., Paradiso, A., Divella, R., Casamassima, P., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030215 · Cited by 9
“Chemotherapy appears to contribute to the patho-physiology of CTIMetS, mainly through gonadal toxicity, inducing decreased levels of estrogen and testosterone, which are associated with central obesity, dyslipidemia and insulin resistance [31,32].”
BackgroundBody Composition and Biological Functioning in Polish Perimenopausal Women with Type 2 Diabetes
Zimny, M., Starczewska, M., Szkup, M., Cybulska, A. M., & Grochans, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111422 · Cited by 8
“Even though the relationship between the menopausal state and decreased sensitivity to insulin has not been fully explained, it is believed that abdominal obesity might be a potential link between the menopausal period and the level of insulin resistance [16,17].”
BackgroundRole of Obesity in Human Health and Disease
Rao, V., & Rao, L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.90990 · Cited by 9
Association of lipid profile with obesity among breast cancer survivors: a cross-sectional study
Okekunle, A. P., Yie, G.-E., Song, S., Kim, Z., Youn, H. J., Cho, J., Min, J. W., Kim, Y. S., & Lee, J. E. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01674-2 · Cited by 9
“Postmenopausal estrogen deficiency has been linked to a constellation of adverse metabolic changes that include dysregulated lipid metabolism [52] and may further be responsible for alterations in the secretion of pancreatic enzymes vital in lipid metabolism [50].”
BackgroundAntioxidative Activity of Smilax china L. Leaf Teas Fermented by Different Strains
Lee, S. I., Lee, Y.-K., Kim, S., Kang, Y. H., & Suh, J. W. (2012) · The Korean Journal of Food And Nutrition · doi:10.9799/ksfan.2012.25.4.807 · Cited by 8
“Tel: +82-31-330-6190; Fax: +82-31-336-0870; E-mail: jwsuh@mju.ac.kr 서 론 경제 개발로 인한 공업화와 더불어 식생활의 서구화로 공 기, 수질을 포함한 환경오염 등 물리, 화학적 환경 변화와 운 동 부족, 대사의 불균형, 각종 스트레스의 증가 등으로 다양한 생활습관병이 크게 증가하고 있다(Carr 2003).”
Riedl, I., Yoshioka, M., & St‐Amand, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.004 · Cited by 9
Quality of life and hypertension after hormone therapy withdrawal in New York City
Warren, M. P., Richardson, O., Chaudhry, S., Shu, A. D., Swica, Y., Sims, V. R., & Sloan, N. L. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31828cfd3b · Cited by 8
Cardiometabolic Risk in Hyperlipidemic Men and Women
Leutner, M., Göbl, C. S., Wielandner, A., Howorka, E., Prünner, M., Bozkurt, L., Harreiter, J., Prosch, H., Schlager, O., Charwat‐Resl, S., et al. (2016) · International Journal of Endocrinology · doi:10.1155/2016/2647865 · Cited by 8
“Female sex hormones relate to higher HDL-cholesterol levels in women and exert overall protective effects against CVD [25, 26].”
BackgroundSong, A., Jiang, S., Wang, Q., Zou, J., Lin, Z., & Gao, X. (2017) · Endocrinology · doi:10.1210/en.2016-1750 · Cited by 9
Shimazu‐Kuwahara, S., Kanemaru, Y., Harada, N., Ikeguchi, E., Ueda, Y., Yamane, S., Murata, Y., Yasoda, A., Kieffer, T. J., & Inagaki, N. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12978 · Cited by 8
Myburgh, P. H., Nienaber‐Rousseau, C., Kruger, I. M., & Towers, G. W. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186646 · Cited by 8
“Health promotion efforts should focus on reducing the individual symptoms that constitute MetS, with public health promotion efforts especially focused on individuals with lower education levels.”
BackgroundInfluentialRelationship between Menopausal Status and Metabolic Syndrome Components in Korean Women
Koh, J. H., Lee, M. Y., Nam, S. M., Sung, J. K., Jung, P. M., Noh, J. K., Shin, J. Y., Shin, Y. G., & Chung, C. H. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.3.243 · Cited by 9
Evidence against a role for ovarian hormones in the regulation of blood flow
Cooper, B. C., Sites, C. K., Fairhurst, P. A., & Toth, M. J. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.017 · Cited by 8
Relationship of Obesity and Bone Mineral Density in Women Dwelling in the Community
강현숙, 김종임, 박원숙, 송라윤, 안양희, 이인옥, 임난영, 조경숙, 최선하, & 한상숙 (2007) · Journal of muscle and joint health · Cited by 8
Choi, M. J., & Yu, J. (2025) · Healthcare · doi:10.3390/healthcare13091062 · Cited by 11
“The metabolic changes occurring in the period approximating menopause include central obesity associated with fat redistribution, relative androgen excess, and a subsequent increase in insulin resistance, which elevate the risk of metabolic syndrome and cardiovascular disease [3,4].”
Menopause and Body Composition: A Complex Field
Juppi, H., Karppinen, J. E., & Laakkonen, E. K. (2025) · Seminars in Reproductive Medicine · doi:10.1055/s-0045-1809531 · Cited by 9
“All rights reserved.”
Metabolic syndrome in menopause
Gumpeny, N., Lakshmi, G., & Sridhar, G. R. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101440 · Cited by 7
Hypothalamic actions of estrogens in the regulation of energy and glucose homeostasis
González‐García, I., & Xu, Y. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09994-1 · Cited by 8
Panay, N., Simoncini, T., Taziaux, M., Bouchard, C., Black, A., Kapoor, E., Utian, W. H., Foidart, J., & Løbo, R. A. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108781 · Cited by 7
Menopause and metabolic health
P'yanykh, O. P., & As, A. (2024) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2024-13-4-94-102 · Cited by 8
Nonhormonal Treatment of Vasomotor Symptoms of Menopause
Goyal, A., Ekelmans, A., Cerjak, J., & Frishman, W. H. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000874 · Cited by 7
Zhang, B., Jiang, D., Ma, H., & Liu, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1623697 · Cited by 8
“This demographic also exhibits a distinct pattern of adiposity distribution, characterized by a greater amount and more concentrated accumulation of visceral fat compared to premenopausal women (15).”
The relationship between serum leptin level and metabolic syndrome in postmenopausal women
Lee, S. W., Cho, H. H., Kim, M. R., Kwon, D. J., Eun Jung, You, Y. O., & Kim, J. H. (2010) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2010.53.3.254 · Cited by 7
“이는 폐경 후 지질대사이상과 비슷한 양상을 보인다.(8) 또한 복부내장지방의 증가는 인슐린 저항성 및 제2형 당뇨 발생증가와 연관이 있다.”
Tsai, S.-H., Tseng, Y.-H., Chiou, W., Chen, S.-M., Chung, Y., Wei, W., & Huang, W.-C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.915483 · Cited by 8
“During the menopausal transition, intra-abdominal fat accumulation, a higher atherogenic lipid profile, and dysfunctional glucose and insulin tolerance are direct and indirect consequences of the resulting estrogen deficiency (6).”
BackgroundAssessment of Blood Pressure Variability in Postmenopausal Women
Jain, A., Kumar, S., Acharya, S., Kabra, R., & Sawant, R. (2022) · Cureus · doi:10.7759/cureus.29471 · Cited by 7
“Few studies have shown a significant increase in blood pressure variability in menopausal women when compared to fertile women, even after exclusion of confounding factors, such as aging and BMI [14-17].”
BackgroundAbelman, R. A., Schneider, M. F., Cox, C., Lambert-Messerlian, G. M., Cohen, M. H., Gustafson, D., Plankey, M. W., Sharma, A., Price, J. C., Grünfeld, C., et al. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003380 · Cited by 7
“13 Body composition changes, which occur during the transition to menopause, result in alterations in adiposity 15 – 17 that may also in fl uence androgen hormone and SHBG levels.”
BackgroundEnhancing Metabolic Syndrome Prediction with Hybrid Data Balancing and Counterfactuals
Shah, S., Mamun, A., Soumma, S. B., & Ghasemzadeh, H. G. (2025) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc58623.2025.11253729 · Cited by 7
An Overview on Germinated Brown Rice and its Nutrigenomic Implications
Imam, M. U., & Ismail, M. (2015) · Wiley eBooks · doi:10.1002/9781118930458.ch39 · Cited by 7
Convergence and divergence of genetic and modular networks between diabetes and breast cancer
Zhang, X., Zhang, Y., Yu, Y., Liu, J., Yuan, Y., Zhao, Y., Li, H., Wang, J., & Wang, Z. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12504 · Cited by 9
“The Increased weight gain of adjuvant chemotherapy or oestrogen suppression may further promote diabetes [5].”
BackgroundQader, S. S., Shakir, Y. A., & Samsioe, G. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0014 · Cited by 7
Wardaningsih, E., Miida, T., Seino, U., Fueki, Y., Ito, M., Nagasaki, K., Kikuchi, T., Uchiyama, M., Hirayama, S., Hanyu, O., et al. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.007237 · Cited by 8
Poirier, N., Légaré, F., Stacey, D., Lemieux, S., Bégin, C., Lapointe, A., & Desroches, S. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.08.011 · Cited by 7
Oxidative Stress in the Visceral Fat Is Elevated in Postmenopausal Women with Gynecologic Cancer
Narumi, M., Takahashi, K., Yamatani, H., Seino, M., Yamanouchi, K., Ohta, T., Takahashi, T., Kurachi, H., & Nagase, S. (2018) · Journal of Women s Health · doi:10.1089/jwh.2016.6301 · Cited by 8
“Middle-aged women gain abdominal subcutaneous fat as they age, but menopause is associated with increases in the amounts of total body fat and abdominal visceral fat,(3) and the prevalence of the metabolic syndrome is higher among postmenopausal women.(4,5) Deficiencies in the levels of estrogen in postmenopausal wome…”
Sexual Dimorphism for the Association between Vitamin D and Insulin Resistance in Chinese People
Han, B., Li, Q., Wang, N., Chen, Y., Zhu, C., Chen, Y., Xia, F., Cang, Z., Lu, M., Meng, Y., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1216370 · Cited by 7
“Estrogen deficiency causes insulin resistance in menopausal women [28].”
BackgroundCholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy
Teixeira, N., Mourits, M. J. E., Oosterwijk, J. C., Fakkert, I. E., Absalom, A. R., Bakker, S. J. L., van der Meer, P., & de Bock, G. H. (2018) · Familial Cancer · doi:10.1007/s10689-018-0091-5 · Cited by 8
Kufe, C. N., Masemola, M., Chikowore, T., Kengne, A. P., Olsson, T., Goedecke, J. H., & Micklesfield, L. K. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024446 · Cited by 7
“13 Premenopausal women have higher insulin sensitivity than their age-matched male counterparts, however, following menopause, this is no longer the case.(14) In both men and women, lower sex hormone binding globulin (SHBG) is associated with an increased risk of T2DM.”
BackgroundHu, H., & Negishi, M. (2020) · Biochemical Journal · doi:10.1042/bcj20200427 · Cited by 7
Maréchal, R., Ghachem, A., Prud’homme, D., RABASA-LHORET, R. P. R., Dionne, I. J., & Brochu, M. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0607 · Cited by 7
Metabolic Syndrome as the First Stage of Eldership; the Beginning of Real Aging
Panov, A. V., Darenskaya, M. A., Dikalov, S., & Kolesnikov, S. I. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95464 · Cited by 8
Vitamin D supplementation is effective for olanzapine-induced dyslipidemia
Zhou, Z., Nagashima, T., Toda, C., Kobayashi, M., Suzuki, T., Nagayasu, K., Shirakawa, H., Asai, S., & Kaneko, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1135516 · Cited by 7
“0%), and higher estrogen levels in females are generally believed to be the reason for better triglyceride control than males (Carr, 2003).”
BackgroundInfluentialIndhavivadhana, S., & Rattanasrithong, P. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3698-x · Cited by 7
“The incidences of increased WC, hypertension, impaired insulin sensitivity and dyslipidemia are reportedly increased in menopausal women [14, 15].”
BackgroundHwu, C., Lin, M., Liou, T., Hsiao, L., Liang, K.-W., Tsai, T.-T., & Ho, L. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31800577856 · Cited by 7
“Dyslipidemia that occurs with menopause is often related to a more atherogenic profile, including increased fasting triglyceride (TG) levels, decreased highdensity lipoprotein cholesterol (HDL-C), and increased small, dense low-density lipoprotein (LDL) particles.(3,4) Moreover, van Beek et al(5) demonstrated that men…”
BackgroundLambrinoudaki, I. V., Tourlakis, D., Armeni, E., Kaparos, G., Rizos, D., Augoulea, A., Alexandrou, A. P., Kreatsa, M., Deligeoroglou, E., & Stamatelopoulos, K. S. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000302 · Cited by 7
“Menopause is associated with a clustering of metabolic alterations, resulting in increased cardiovascular risk.(1,31,32) Subclinical atherosclerosis is highly prevalent after menopause,(3) whereas only end-stage renal disease has been included among potential cardiovascular risk factors.”
BackgroundTam, F. I., Huebner, A., Hofbauer, L. C., & Rohayem, J. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0005 · Cited by 7
“However, the magnitude of the impact of estrogen deficiency independent of other factors, for example, aging, on these changes has not been conclusively clarified (7, 18).”
BackgroundDPP4 activity is related to body weight and central fat in postmenopausal women
Siciliano, P. D. O., Godoy‐Matos, A. F., Braga, L. D. D. C., Carvalho, J. D. P., & Corrêa, J. O. D. A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.07.008 · Cited by 7
Basurto, L., Díaz, A., Rodriguez, A., Robledo, A., la Vega, S. M. D., Garcia-Vega, J., & Murillo, C. M. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1604658 · Cited by 9
“risk due to changes in their body fat distribution, lipid profile, insulin resistance and hypofibrinolysis [7,8].”
Jung, J. Y., Park, S. K., Oh, C., Choi, J., Ryoo, J., Kim, J., & Kim, M. K. (2019) · Endocrine · doi:10.1007/s12020-019-01980-3 · Cited by 7
Akgöz, A. D., Özer, Z., & Gözüm, S. (2020) · Health Care For Women International · doi:10.1080/07399332.2020.1828422 · Cited by 7
“Although CVD rarely seen in women under the age of 50, the risk of CVD increases similarly in both men and women after 55 years of age, and the incidence of CVD is equalized in men and women by the age of 70 (Carr, 2003).”
BackgroundPoret, J. M., Guidry, J. J., Simon, L., & Molina, P. E. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00001.2021 · Cited by 7
Gaining weight and components of metabolic syndrome in the period of menopause
Simoncig-Netjasov, A., Vujović, S., Ivović, M., Tančić‐Gajić, M., & Drezgić, M. (2008) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0810505s · Cited by 7
“Me no pa u za, pre ko raz vo ja cen tralne go ja zno sti i ate ro ge nog li pid nog pro fi la, po veæa va ri zik od na stan ka MS za 60%, ne za vi sno od staro sti, in dek sa te le sne ma se (ITM) i fi ziè ke ak tivno sti [4, 5].”
BackgroundGrunstein, R. R. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50112-9 · Cited by 10
Hypertension in Women Across the Life Cycle: Unique Aspects and Challenges
Bond, R. M., Purewal, V. S., Cameron, N. A., Tobb, K., Adedinsewo, D. A., Isiadinso, I., & Phillips, K. A. (2026) · Current Hypertension Reports · doi:10.1007/s11906-026-01362-x · Cited by 6
Screening and Management Recommendations for Type 2 Diabetes in Women With Breast Cancer
Scott, L. J., Truong, L.-L., Houlden, R. L., & Wijeratne, D. T. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.07.008 · Cited by 8
Huang, S.-Y., Chung, M., Kung, C.-W., Chen, S., Chen, Y., Pan, T., Cheng, P., Shen, H., & Lee, Y. (2024) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23048 · Cited by 6
MetS ‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes
Hsu, P. W., Chen, Y., & Sheu, W. H. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70004 · Cited by 6
“These fi ndings align with prior research linking WC to disruptions in glucose homeostasis, particularly in postmenopausal women 16 – 20 .”
He, L., Zhang, X., Lv, Y., Gu, B., & Zhao, L. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001364 · Cited by 7
“The increased abdominal fat deposition caused by low estrogen in postmenopausal women implies that hormonal changes contribute more to changes in body fat distribution than general obesity.(20) Our study found that postmenopausal women with the ACE DD genotype had a significantly higher mean BMI than I-allele carriers…”
BackgroundEndocrine Disorders Accompanying Obesity - Effect or Cause?
Kuryłowicz, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98793 · Cited by 8
García‐Arévalo, M., Lorza‐Gil, E., Leite, N. C., Brunetto, S. Q., Boschero, A. C., & Carneiro, E. M. (2019) · Journal of Endocrinology and Metabolism · doi:10.14740/jem612 · Cited by 6
“In menopausal women, there is a decline in insulin sensitivity concomitant with an increase in fat mass and higher levels of circulating inflammatory markers [52].”
BackgroundMenopause: Questions and Answers for Improving Homeopathic Clinical Practice
Macías-Cortés, E. D. C. (2022) · Homeopathy · doi:10.1055/s-0042-1755362 · Cited by 8
“…and coronary heart disease) 35 – 39 ; (2) musculoskeletal diseases (osteoporosis, sarcopenia and osteoarthritis) 40 – 42 ; (3) metabolic syndrome 43 ; (4) diabetes 43,44 ; (5) chronic respiratory disease 35 ; (6) cancer (lung, breast, colorectal, pancreatic, ovarian and cervical) 35,45 – 48 ;…”
Peng, W., Han, M., & Xu, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030779 · Cited by 6
“Some indicated physical activity strongly affected parameters related to cardiovascular function, with large differences in the magnitude by gender, while others reported opposite, even null correlation [17,22,23].”
BackgroundMin, S. H., Docherty, S. L., Im, E., Hu, X. P., Hatch, D., & Yang, Q. (2023) · Women s Health · doi:10.1177/17455057231160955 · Cited by 6
“8 These midlife peri-menopausal and post-menopausal women with metabolic syndrome experience multiple co-occurring symptoms or symptom clusters that often result in significant symptom burden because they experience symptoms associated with both menopause and metabolic syndrome concurrently.”
BackgroundBrian, M. S., Chaudhry, B. A., D’Amelio, M. P., Waite, E. E., Dennett, J. G., O'Neill, D. F., & Feairheller, D. L. (2024) · Journal of Sports Sciences · doi:10.1080/02640414.2024.2363688 · Cited by 6
“It is known that women may have a reduced risk of cardiometabolic disease during young adulthood (Carr, 2003; Sugiyama & Agellon, 2012) but whether seemingly healthy young women would also benefit from post-prandial walking remains unknown.”
BackgroundKonrad, T., Bär, F., Schneider, F., Franke, S., Böhles, H., Vetter, G., & Balkau, B. (2011) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111416139 · Cited by 8
“234 Diabetes and Vascular Disease Research 8(3)”
BackgroundMethodInfluentialBarbat‐Artigas, S., Filion, M., Ringuet, M.-È., Aubertin‐Leheudre, M., & Karelis, A. D. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.08.001 · Cited by 7
Relationship of gender and lipid profile with cardiac parasympathetic reactivity
Chaudhuri, A., Saha, S., & Borade, N. (2012) · Journal of Basic and Clinical Reproductive Sciences · doi:10.4103/2278-960x.104293 · Cited by 6
“[1,2] Strengths of study Premenopausal women,[1] as compared with young men showed better responses to parasympathetic function tests.”
BackgroundResultInfluentialGabriel, K. P., Storti, K. L., Conroy, M. B., & Ainsworth, B. E. (2008) · American Journal of Lifestyle Medicine · doi:10.1177/1559827608320132 · Cited by 6
“The lack of estrogen is thought to be related to unfavorable changes in cardiovascular risk factors.(8) Cross-sectional data suggest that changes in the hormonal milieu that occurs during the menopausal transition are associated with negative body composition changes (ie, decreased skeletal muscle mass,(9-12) increase…”
BackgroundInfluentialZagayko, A. L., Kravchenko, G., Strelchenko, K. V., Shkapo, A. I., & Брюханова, Т. О. (2015) · InTech eBooks · doi:10.5772/60759 · Cited by 6
“It is also known that MS at a younger age is more common in men, but in women the incidence of MS increases gradually with age – especially during menopause [13, 78].”
BackgroundPrevalence of Metabolic Syndrome in Saudi Population
Aljabri, K. S. (2018) · Archives of Diabetes & Obesity · doi:10.32474/ado.2018.01.000112 · Cited by 6
“In females, menopause and estrogen deficiency appears to be independent predisposing factor for the development of most of the components of the MetS [46,47].”
BackgroundChoi, H.-G., & Kim, H.-J. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001569 · Cited by 6
“Postmenopausal women experience accumulation of visceral fat due to estrogen deficiency,(1) which leads to abdominal obesity in addition to an increase in the level of triglycerides, total cholesterol, and low-density lipoprotein cholesterol in blood, and also fasting blood glucose and blood pressure.(3) Theses physic…”
BackgroundHussain, Z. K. (2022) · Iraqi Journal of Science · doi:10.24996/ijs.2022.63.12.5 · Cited by 10
Relationship between serum adipocytokine levels and metabolic syndrome in menopausal women
Park, H. T., Cho, S. H., Cho, G. J., Shin, J., Hong, S., Kim, T., Hur, J. Y., Kim, Y. T., & Kim, S. H. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802404021 · Cited by 6
“In many women, features of metabolic syndrome, such as insulin resistance and dyslipidemia, emerge concurrently with estrogen deficiency [2].”
Backgroundde Oliveira, M. C., Martins-Maciel, E. R., Comar, J. F., Yamamoto, N. S., Bracht, A., Ishii‐Iwamoto, E. L., & Salgueiro‐Pagadigorria, C. L. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.043 · Cited by 6
Chang, S. J., Chee, W., & Im, E. (2013) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/1552-6909.12261 · Cited by 6
“Among these factors, the BMI, which is related not only to menopause age and menopausal symptoms but also to metabolic syndrome and cardiovascular disease after menopause, is considered an important factor in many menopausal symptomsrelated studies because the BMI has the potential to be modified through interventions…”
BackgroundChaudhuri, A. C. D. A. (2014) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-0411-01-05 · Cited by 6
Kwon, E., Nah, E., Kim, H., Joe, S.-H., & Cho, H.-I. (2016) · Daehan imsang geon-gang jeungjin hakoeji/Daehan imsang geon'gang jeungjin haghoeji · doi:10.15384/kjhp.2016.16.2.119 · Cited by 6
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.